4-[5-[(1S)-1-aminospiro[1,3-dihydroindene-2,4'-piperidine]-1'-yl]pyrazin-2-yl]sulfanyl-3-chloro-1H-pyridin-2-one
C22H22ClN5OS — CID 142434039
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[5-[(1S)-1-aminospiro[1,3-dihydroindene-2,4'-piperidine]-1'-yl]pyrazin-2-yl]sulfanyl-3-chloro-1H-pyridin-2-one
4-[5-[(1S)-1-aminospiro[1,3-dihydroindene-2,4'-piperidine]-1'-yl]pyrazin-2-yl]sulfanyl-3-chloro-1H-pyridin-2-one (PubChem CID 142434039) has the molecular formula C22H22ClN5OS and a molecular weight of 439.97 g/mol. Its IUPAC name is 4-[5-[(1S)-1-aminospiro[1,3-dihydroindene-2,4'-piperidine]-1'-yl]pyrazin-2-yl]sulfanyl-3-chloro-1H-pyridin-2-one.
Molecular Properties
| Compound Name | 4-[5-[(1S)-1-aminospiro[1,3-dihydroindene-2,4'-piperidine]-1'-yl]pyrazin-2-yl]sulfanyl-3-chloro-1H-pyridin-2-one |
|---|---|
| PubChem CID | 142434039 |
| Molecular Formula | C22H22ClN5OS |
| Molecular Weight | 439.97 g/mol |
| Exact Mass | 439.12 |
| IUPAC Name | 4-[5-[(1S)-1-aminospiro[1,3-dihydroindene-2,4'-piperidine]-1'-yl]pyrazin-2-yl]sulfanyl-3-chloro-1H-pyridin-2-one |
| SMILES | N[C@@H]1c2ccccc2CC12CCN(c1cnc(Sc3cc[nH]c(=O)c3Cl)cn1)CC2 |
| InChI | InChI=1S/C22H22ClN5OS/c23-19-16(5-8-25-21(19)29)30-18-13-26-17(12-27-18)28-9-6-22(7-10-28)11-14-3-1-2-4-15(14)20(22)24/h1-5,8,12-13,20H,6-7,9-11,24H2,(H,25,29)/t20-/m1/s1 |
| InChIKey | AUNJMFSHBXABDE-HXUWFJFHSA-N |
| XLogP | 3.81 |
| TPSA | 87.90 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 439.97 |
| LogP ≤ 5 | 3.81 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142434039 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.